James M. Daly - 11 Aug 2023 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
Director
Signature
/s/ James Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
11 Aug 2023
Net transactions value
-$874,520
Form type
4
Filing time
15 Aug 2023, 16:04:28 UTC
Previous filing
20 Jun 2023
Next filing
03 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Sale $437,110 -10,000 -25% $43.71 30,503 11 Aug 2023 Direct F1
transaction HALO Common Stock Sale $437,410 -10,000 -33% $43.74 20,503 14 Aug 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a weighted average sales price per share. These shares were sold at prices ranging from $43.63 to $43.86. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2 Represents a weighted average sales price per share. These shares were sold at prices ranging from $43.54 to $44.16. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.